Elutia Inc.
Elutia develops drug-eluting biomatrix products for implantable medical devices designed to improve biocompatibility.
10-QNov 10Latest SEC filing
Nov 5Latest story
Elutia develops drug-eluting biomatrix products for implantable medical devices designed to improve biocompatibility.
November 2026
August 2026
July 2026